DR. SAMANTHA JEAN MERCK M.D.
Prescription History 1467890921
Internal Medicine - Pulmonary Disease in Tulsa, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SAMANTHA JEAN MERCK M.D., an active Pulmonary Disease specialist practicing in Tulsa, OK. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 354 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 96 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 96 | $693.50▼ below OK avg | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2024, this provider wrote 96 Medicare prescriptions for Trelegy Ellipta, about 1.6 times the volume of the typical Oklahoma prescriber of this medication (58.7). Medicare paid an average of $693.50 per fill, versus $823.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 107 30-Day Fills standardized to 30-day supplies 3,210 Days of Medication total across all patients in 2024 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 68 | $26.97▼ below OK avg | ≈ Typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 68 Medicare prescriptions for Albuterol Sulfate Hfa, about the same volume as the typical Oklahoma prescriber of this medication (67.9). Medicare paid an average of $26.97 per fill, versus $28.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 82.8 30-Day Fills standardized to 30-day supplies 2,187 Days of Medication total across all patients in 2024 | |||
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 49 | $745.85▼ below OK avg | ▲ More than typical |
About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma. In 2024, this provider wrote 49 Medicare prescriptions for Breztri Aerosphere, about 1.4 times the volume of the typical Oklahoma prescriber of this medication (36.2). Medicare paid an average of $745.85 per fill, versus $773.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 59 30-Day Fills standardized to 30-day supplies 1,770 Days of Medication total across all patients in 2024 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 22 | $713.68 | ≈ Typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 22 Medicare prescriptions for Stiolto Respimat, about 76% of the volume of the typical Oklahoma prescriber of this medication (29). Medicare paid an average of $713.68 per fill, versus $604.10 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| Prednisone | 17 | $6.27 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 17 Medicare prescriptions for Prednisone, about a third of the volume of the typical Oklahoma prescriber of this medication (45.6). Medicare paid an average of $6.27 per fill, versus $3.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 617 Days of Medication total across all patients in 2024 | |||
| Montelukast Sodium | 16 | $12.18▼ below OK avg | ▼ Less than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. A leukotriene D4 receptor antagonist. In 2024, this provider wrote 16 Medicare prescriptions for Montelukast Sodium, about a quarter of the volume of the typical Oklahoma prescriber of this medication (75.3). Medicare paid an average of $12.18 per fill, versus $16.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $437.88▼ below OK avg | ▼ Less than typical |
About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 14 Medicare prescriptions for Anoro Ellipta, about half the volume of the typical Oklahoma prescriber of this medication (26.9). Medicare paid an average of $437.88 per fill, versus $548.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $124.85▼ below OK avg | ▼ Less than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 13 Medicare prescriptions for Fluticasone-Salmeterol, about half the volume of the typical Oklahoma prescriber of this medication (26.8). Medicare paid an average of $124.85 per fill, versus $139.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Ipratropium Bromide | 13 | $10.58▼ below OK avg | ▼ Less than typical |
About Ipratropium Bromide: Ipratropium is used to treat a runny nose caused by the common cold or seasonal allergies. Show more ▾ It works by reducing the amount of fluid/mucus released from inside your nose. This medication does not relieve symptoms of stuffy nose or sneezing. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. In 2024, this provider wrote 13 Medicare prescriptions for Ipratropium Bromide, about a third of the volume of the typical Oklahoma prescriber of this medication (38.6). Medicare paid an average of $10.58 per fill, versus $28.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 13 30-Day Fills standardized to 30-day supplies 143 Days of Medication total across all patients in 2024 | |||
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 12 | $118.44 | ▼ Less than typical |
About Levalbuterol Tartrate Hfa: Levalbuterol is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is a quick-relief drug. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This drug is not approved for use in children younger than 4 years due to increased risk of side effects (such as unusual fast breathing, worsening asthma). Ask your doctor or pharmacist for details. The R-isomer of albuterol. In 2024, this provider wrote 12 Medicare prescriptions for Levalbuterol Tartrate Hfa, about 70% of the volume of the typical Oklahoma prescriber of this medication (17.2). Medicare paid an average of $118.44 per fill, versus $62.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16.7 30-Day Fills standardized to 30-day supplies 475 Days of Medication total across all patients in 2024 | |||
| Pirfenidone | 12 | $762.38▼ below OK avg | ▼ Less than typical |
About Pirfenidone: Pirfenidone is used to treat a certain lung disease called idiopathic pulmonary fibrosis (IPF). Show more ▾ This disease causes the lungs to get scarred and become stiff, making it hard to breathe. Pirfenidone may help slow down the worsening of your IPF. In 2024, this provider wrote 12 Medicare prescriptions for Pirfenidone, about half the volume of the typical Oklahoma prescriber of this medication (21.3). Medicare paid an average of $762.38 per fill, versus $1,434.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Incruse ElliptaUmeclidinium Bromide | 11 | $331.34▼ below OK avg | ▼ Less than typical |
About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Muscarinic Antagonist. In 2024, this provider wrote 11 Medicare prescriptions for Incruse Ellipta, about half the volume of the typical Oklahoma prescriber of this medication (21.6). Medicare paid an average of $331.34 per fill, versus $390.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 11 | $19.20 | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 11 Medicare prescriptions for Omeprazole, about 10% of the volume of the typical Oklahoma prescriber of this medication (106.8). Medicare paid an average of $19.20 per fill, versus $18.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. SAMANTHA JEAN MERCK M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Tulsa, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
